Lawsuits Over Ozempic, Wegovy, Mounjaro and Other GLP1-RA Drugs May Hinge on Label Warnings Lawyers indicate that that questions about whether the GLP-1 RA medication label warnings adequately disclose the risk of gastroparesis and other severe injuries will play a large role in the growing litigation
The specific percentage retained has been the subject of intense regulatory scrutiny and, in at least one case, a federal lawsuit
You are actively damaging the peptide and compromising your results by doing this
Scott is our resident industry pioneer, prioritizing the patient-provider relationship with consideration, time, and knowledge
Patients notice better sleep, less brain fog, radiant skin, and greater energy after one treatment